OPKO Health Announces Topline Results from Phase 2 Trial Evaluating RAYALDEE to Treat Symptomatic COVID-19 OutpatientsGlobeNewsWire • 12/23/21
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.PRNewsWire • 11/29/21
OPKO Health's (OPK) CEO Phillip Frost on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/29/21
OPKO Health Reports 2021 Third Quarter Business Highlights and Financial ResultsGlobeNewsWire • 10/28/21
OPKO Health to Report Third Quarter 2021 Financial Results on October 28, 2021GlobeNewsWire • 10/25/21